食品科学 ›› 2023, Vol. 44 ›› Issue (19): 118-130.doi: 10.7506/spkx1002-6630-20230603-018

• 营养卫生 • 上一篇    

从人体肠道菌群及脂代谢的角度比较水苏糖与益生菌纠正肠道失衡的能力

汪清美,赵培,陈庆森,贾彦,闫亚丽   

  1. (1.信阳农林学院制药工程学院,河南 信阳 464000;2.天津商业大学生物技术与食品科学学院,天津 300134)
  • 发布日期:2023-11-07
  • 基金资助:
    国家自然科学基金面上项目(31071522)

Comparative Efficacy of Stachyose and Probiotics in Ameliorating Intestinal Dysbiosis from the Perspectives of Human Gut Microbiota and Lipid Metabolism

WANG Qingmei, ZHAO Pei, CHEN Qingsen, JIA Yan, YAN Yali   

  1. (1. School of Pharmaceutical Engineering, Xinyang Agriculture and Forestry University, Xinyang 464000, China;2. College of Biotechnology and Food Science, Tianjin University of Commerce, Tianjin 300134, China)
  • Published:2023-11-07

摘要: 人体肠道菌群与健康息息相关,一旦肠道菌群失调会导致肠道功能紊乱,引发多种肠道疾病。本实验通过不同肠道疾病人群服用水苏糖、复合益生菌(compound probiotics,CPb)和合生元MF-13,利用Ion Torrent PGM™测序平台等手段,重点关注粪便中肠道菌群结构以及胆固醇和胆汁酸含量的变化,探讨3 种微生态制剂干预过程中志愿者肠道菌群结构和脂代谢的变化情况。结果显示,不同肠道疾病人群经微生态制剂干预后,分析获得1 067 个操作分类单元(operational taxonomic units,OTU);优势菌门为厚壁菌门(Firmicutes)和拟杆菌门(Bacteroidetes),二者占到了总序列数的91.65%,其中拟杆菌门(Bacteroidetes)约占总序列数的70.10%,其门下的拟杆菌属(Bacteroides)和普雷沃氏菌属(Prevotella)为优势菌属,分别占总序列数的33.1%和33.8%。在门水平上,水苏糖能促进拟杆菌门而抑制厚壁菌门菌群的增殖,CPb对各菌门丰度变化趋势的影响不明显,MF-13对变形菌门和放线菌门菌群的增殖有促进作用;3 组微生态制剂干预前后菌属丰度变化结果显示,水苏糖引起便秘和失眠样本中的萨特菌属的丰度明显降低,CPb引起腹泻样本中萨特菌属显著降低;MF-13引起Parabacteroides的丰度升高。通过对肠道菌群多样性分析发现,仅Chao1指数在MF-13干预组在干预前期明显升高,其他多样性指数无明显性变化。对肠道菌群结构变化进行聚类和无度量多维标定(non-metric multi-dimensional scaling,NMDS)分析,结果显示大部分样本在微生态制剂干预过程中菌群结构都产生变化,各群体间菌群结构有相互交叠的趋势。利用Metastat统计学分析个体之间存在显著差异的肠道菌群,发现各微生态制剂干预前后整体OTUs丰度无明显变化,在志愿者个体之间差异较大。MF-13对肠道胆固醇和胆汁酸的排出有显著促进作用(P<0.05)。结论:水苏糖对志愿者肠道菌群结构的影响显著,而CPb和MF-13的影响不显著,但MF-13能够促进肠道胆固醇和胆汁酸的排放,有利于肠道胆固醇的代谢,但干预的持续性不明显。

关键词: 肠道菌群;微生态制剂;高通量测序技术;胆固醇;胆汁酸

Abstract: The intestinal flora of the human body is closely related to health. Gut microbiota dysbiosis will lead to intestinal dysfunction and, consequently, a variety of intestinal diseases. In this study, subjects with different diseases were requested to take one of three microecological agents, stachyose, composite probiotics (CPb) and synbiotic MF-13. An Ion Torrent PGM™ sequencing platform was used to analyze the structure of intestinal microflora and the contents of cholesterol and bile acid in the feces of the subjects were measured. Our aim was to investigate the regulatory effect of intervention with microecological agents on the intestinal microflora structure and lipid metabolism. The results showed that 1 067 operational taxonomic units (OUT) were obtained from the fecal microbial samples from all subjects. The dominant bacteria were Firmicutes and Bacteroidetes, altogether accounting for 91.65%, and Bacteroidetes accounting for about 70.10% of the total number of sequences. Bacteroides and Prevotella were the dominant genera, accounting for 33.1% and 33.8% of the total sequences, respectively. At the phylum level, stachyose promoted the proliferation of Bacteroidetes, but inhibited the proliferation of Firmicutes. CPb had no significant effect on the abundance of each phylum, while MF-13 promoted the proliferation of Proteobacteria and Actinobacteria. Stachyose significantly decreased the abundance of Sutterella in subjects with constipation and insomnia, CPb significantly decreased the abundance of Sutterella in subjects with diarrhea, and MF-13 increased the abundance of Parabacteroides. The analysis of intestinal microflora diversity showed that Chao1 index significantly increased during the early period of MF-13 intervention, while there were no significant changes in other diversity indexes. Cluster analysis and non-metric multi-dimensional scaling (NMDS) analysis showed that microecological preparation intervention changed the intestinal microbiota structure in most of the samples, and the microflora structure of all populations showed an overlapping tendency. The intestinal microflora species that significantly differed between individuals were analyzed using Metastat statistics, and it was found that there was no significant change in the abundance of OTUs before and after intervention with each microecological agent, while there was a significant difference between individual subjects. MF-13 significantly promoted the fecal excretion of cholesterol and bile acids (P < 0.05). In conclusion, stachyose has an obvious influence on the intestinal microflora structure of volunteers, while CPb and MF-13 do not. However, MF-13 can increase the intestinal excretion of cholesterol and bile acid, which is beneficial to the metabolism of intestinal cholesterol, but the durability of this effect is poor.

Key words: gut microbiota; microecological agents; high-throughput sequencing technology; cholesterol; bile acids

中图分类号: